Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Till KJ et al. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells. 2015 J. Immunol. pmid:25632006
Zhong Y et al. Nephrokeli, a Chinese herbal formula, may improve IgA nephropathy through regulation of the sphingosine-1-phosphate pathway. 2015 PLoS ONE pmid:25633986
Sivasubramanian M et al. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro. 2015 Neuroscience pmid:25637806
Kalhori V and Törnquist K MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. 2015 Mol. Cell. Endocrinol. pmid:25643979
Breslin JW et al. Involvement of local lamellipodia in endothelial barrier function. 2015 PLoS ONE pmid:25658915
Ji F et al. K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling. 2015 Biochem. Biophys. Res. Commun. pmid:25680461
Cheng Y et al. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP. 2015 FASEB J. pmid:25690654
Rhee SH et al. Pelvic organ prolapse is associated with alteration of sphingosine-1-phosphate/Rho-kinase signalling pathway in human vaginal wall. 2015 J Obstet Gynaecol pmid:25692679
Park ES et al. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction. 2015 J. Biol. Chem. pmid:25716317
Koch A et al. Downregulation of sphingosine 1-phosphate (S1P) receptor 1 by dexamethasone inhibits S1P-induced mesangial cell migration. 2015 Biol. Chem. pmid:25719311
Schröder M et al. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application. 2015 Biol. Chem. pmid:25720062
Zhang DD et al. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors. 2015 Biol. Chem. pmid:25720064
Lin CC et al. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation. 2015 PLoS ONE pmid:25734900
Moolenaar WH Introduction to the ECR special issue on lysophospholipids in biology. 2015 Exp. Cell Res. pmid:25746723
Zhao S and Li J Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathway. 2015 PLoS ONE pmid:25748447
Ueda N Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate. 2015 Int J Mol Sci pmid:25751724
Carrera I et al. A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease. 2015 Biomed Res Int pmid:25759822
Kang H et al. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension. 2015 Stem Cells Dev. pmid:25761906
Muñoz-Sáez E et al. Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y). 2015 Neurosci. Lett. pmid:25769802
Newton J et al. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. 2015 Exp. Cell Res. pmid:25770011
Nojima H et al. Sphingolipids in liver injury, repair and regeneration. 2015 Biol. Chem. pmid:25781682
Brulhart-Meynet MC et al. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. 2015 PLoS ONE pmid:25781943
Kasbi-Chadli F et al. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. 2016 Eur J Nutr pmid:25787885
Castillo-Badillo JA et al. α1B-adrenergic receptors differentially associate with Rab proteins during homologous and heterologous desensitization. 2015 PLoS ONE pmid:25799564
Potì F et al. SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. 2015 Atherosclerosis pmid:25801013
Salama MF et al. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. 2015 FASEB J. pmid:25805832
Lee SY et al. Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice. 2015 Hepatology pmid:25808625
Proia RL and Hla T Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. 2015 J. Clin. Invest. pmid:25831442
Nussbaum C et al. Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin. 2015 Nat Commun pmid:25832730
Riley RT et al. A blood spot method for detecting fumonisin-induced changes in putative sphingolipid biomarkers in LM/Bc mice and humans. 2015 Food Addit Contam Part A Chem Anal Control Expo Risk Assess pmid:25833119
Molinari G Is hydrogen ion (H(+)) the real second messenger in calcium signalling? 2015 Cell. Signal. pmid:25843778
Ren K et al. Apolipoprotein M. 2015 Clin. Chim. Acta pmid:25858547
Kolahdooz Z et al. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism. 2015 Can J Neurol Sci pmid:25860537
Wang L et al. Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate. 2015 Microvasc. Res. pmid:25862132
Ohkawa R et al. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects. 2015 Clin. Biochem. pmid:25863111
Egom EE et al. The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue. 2015 J. Cell. Mol. Med. pmid:25864579
Jernigan PL et al. The role of sphingolipids in endothelial barrier function. 2015 Biol. Chem. pmid:25867999
Wilson PC et al. Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. 2015 Mol. Endocrinol. pmid:25871850
Wang Z et al. The Effect of Sphingosine 1-Phosphate/Sphingosine 1-Phosphate Receptor on Neutrophil Function and the Relevant Signaling Pathway. 2015 Acta Haematol. pmid:25872153
Williams PA et al. Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P). 2015 PLoS ONE pmid:25875493
Li C et al. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3. 2015 J Neuroinflammation pmid:25880547
Zankov DP and Ogita H Actin-tethered junctional complexes in angiogenesis and lymphangiogenesis in association with vascular endothelial growth factor. 2015 Biomed Res Int pmid:25883953
Pulli I et al. A novel chimeric aequorin fused with caveolin-1 reveals a sphingosine kinase 1-regulated Ca²⁺ microdomain in the caveolar compartment. 2015 Biochim. Biophys. Acta pmid:25892494
Chimen M et al. Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. 2015 Nat. Med. pmid:25894827
Farnoud AM et al. The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway. 2015 Infect. Immun. pmid:25895971
Benesch MG et al. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate. 2015 J. Lipid Res. pmid:25896349
Boczkowska-Radziwon B et al. Ozonation of human blood increases sphingosine-1-phosphate in plasma. 2015 J. Physiol. Pharmacol. pmid:25903957
Deng Z et al. Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis. 2015 Nat Commun pmid:25907800
Hyder CL et al. Sphingolipids inhibit vimentin-dependent cell migration. 2015 J. Cell. Sci. pmid:25908861
Stone ML et al. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25910934
Japtok L et al. Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2. 2015 FASEB J. pmid:25911610
Ader I et al. Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer. 2015 Oncotarget pmid:25915662
Pulkoski-Gross MJ et al. Sphingosine-1-phosphate metabolism: A structural perspective. 2015 Crit. Rev. Biochem. Mol. Biol. pmid:25923252
Trayssac M et al. Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody. 2015 Am. J. Transplant. pmid:25930666
Rosenberg AJ et al. A practical process for the preparation of [(32)P]S1P and binding assay for S1P receptor ligands. 2015 Appl Radiat Isot pmid:25931137
Prager B et al. Sphingosine 1-phosphate signaling at the blood-brain barrier. 2015 Trends Mol Med pmid:25939882
Kulinski JM et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. 2016 Eur. J. Pharmacol. pmid:25941085
Rahman MM et al. Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs. 2015 Biochem. Biophys. Res. Commun. pmid:25951977
Laurenzana A et al. Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts. 2015 J. Mol. Med. pmid:25952146
Jing XD et al. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis. 2015 Clin. Chim. Acta pmid:25958848
Morad SA and Cabot MC Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications. 2015 Biochim. Biophys. Acta pmid:25964209
Lee KP et al. DJ-1-mediated upregulation of serine palmitoyltransferase 2 controls vascular neointima via S1P autocrine. 2015 Int. J. Cardiol. pmid:25978603
Schweitzer KS et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. 2015 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:25979079
Kim ES et al. A natural piper-amide-like compound NED-135 exhibits a potent inhibitory effect on the invasive breast cancer cells. 2015 Chem. Biol. Interact. pmid:25980589
Parham KA et al. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis. 2015 FASEB J. pmid:25985799
Zhang JN et al. The role of the sphingosine-1-phosphate signaling pathway in osteocyte mechanotransduction. 2015 Bone pmid:25988659
Liu G et al. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling. 2015 J. Pathol. pmid:25988668
Książek M et al. Sources, metabolism, and regulation of circulating sphingosine-1-phosphate. 2015 J. Lipid Res. pmid:26014962
Durham JT et al. Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy? 2015 Invest. Ophthalmol. Vis. Sci. pmid:26030100
Binder BY et al. Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering. 2015 Tissue Eng Part B Rev pmid:26035484
Wang J et al. Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis. 2015 Biomaterials pmid:26036174
Tian H and Yu Z Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway. 2015 Int J Clin Exp Pathol pmid:26045781
Blaho VA et al. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. 2015 Nature pmid:26053123
Mooren OL et al. Role of N-WASP in Endothelial Monolayer Formation and Integrity. 2015 J. Biol. Chem. pmid:26070569
Malik FA et al. Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity. 2015 PLoS ONE pmid:26079370
Panneer Selvam S et al. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. 2015 Sci Signal pmid:26082434
Chen MH et al. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. 2015 Oncotarget pmid:26090720
Sutter I et al. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL. 2015 Atherosclerosis pmid:26093887
Rumzhum NN et al. Effect of Sphingosine 1-Phosphate on Cyclo-Oxygenase-2 Expression, Prostaglandin E2 Secretion, and β2-Adrenergic Receptor Desensitization. 2016 Am. J. Respir. Cell Mol. Biol. pmid:26098693
Marycz K et al. The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells--new opportunities in regenerative medicine. 2015 Cell. Mol. Biol. Lett. pmid:26110483
Jeong SK et al. Sphingosine kinase 1 activation enhances epidermal innate immunity through sphingosine-1-phosphate stimulation of cathelicidin production. 2015 J. Dermatol. Sci. pmid:26113114
Nakagawa Y and Chiba K Diversity and plasticity of microglial cells in psychiatric and neurological disorders. 2015 Pharmacol. Ther. pmid:26129625
Urtz N et al. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo. 2015 Circ. Res. pmid:26129975
Yagi K et al. Therapeutically Targeting Tumor Necrosis Factor-α/Sphingosine-1-Phosphate Signaling Corrects Myogenic Reactivity in Subarachnoid Hemorrhage. 2015 Stroke pmid:26138121
Denimal D et al. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration. 2015 Atherosclerosis pmid:26142685
Gao Y et al. Sphingosine kinase 1 as an anticancer therapeutic target. 2015 Drug Des Devel Ther pmid:26150697
Schaffert SA et al. mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function. 2015 J. Immunol. pmid:26163591
Checa A et al. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment. 2015 Sci Rep pmid:26174087
Michels M et al. Decreased plasma levels of the endothelial protective sphingosine-1-phosphate are associated with dengue-induced plasma leakage. 2015 J. Infect. pmid:26183296
Vettorazzi S et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. 2015 Nat Commun pmid:26183376
Airola MV et al. Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase. 2015 Structure pmid:26190575
Spampinato SF et al. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli? 2015 PLoS ONE pmid:26197437
Manes NP et al. Targeted Proteomics-Driven Computational Modeling of Macrophage S1P Chemosensing. 2015 Mol. Cell Proteomics pmid:26199343
Wang H et al. Sphingosine-1-Phosphate Induces the Migration and Angiogenesis of Epcs Through the Akt Signaling Pathway via Sphingosine-1-Phosphate Receptor 3/Platelet-Derived Growth Factor Receptor-β. 2015 Cell. Mol. Biol. Lett. pmid:26208383
Adada MM et al. Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion. 2015 FASEB J. pmid:26209696
Kim BJ et al. The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient. 2016 J. Endocrinol. Invest. pmid:26219613
Gao XY et al. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications. 2015 Oncol. Rep. pmid:26239167
Kharel Y et al. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels. 2015 J. Pharmacol. Exp. Ther. pmid:26243740
Yester JW et al. Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop. 2015 FASEB J. pmid:26246404
Nojima H et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. 2016 J. Hepatol. pmid:26254847